A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early [vs. delayed] introduction of everolimus in de novo kidney transplant recipients, with a follow-up evaluation at 12 month after transplant (NEVERWOUND study)

Academic Article

Publication Date:

2020

abstract:

The risk of Wound Healing Complications (WHC) and the early use of mTORi after Kidney Transplantation (KT) have not been fully addressed.

Iris type:

1.1 Articolo in rivista

List of contributors:

Handle:

Published in:

Journal